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Abstract
Autism is a neuropsychiatric disorder characterized by impairments in reciprocal
social interaction and communication, and the presence of restricted and repetitive
behaviours. Autism is predominantly heritable, but the underlying genetic associa-
tions are still largely unknown. Understanding the genetic background of complex
diseases, such as autism, plays an essential role in the promising precision medicine.
The evaluation of candidate genes, however, requires time-consuming and expensive
experiments given the large number of possibilities. Thus, computational methods
have seen increasing applications in predicting gene-disease associations. In this the-
sis, we proposed a bioinformatics framework, Prioritization of Autism-genes using
Network-based Deep-learning Approach (PANDA). Our approach aims to identify
autism-genes across the human genome based on patterns of gene-gene interactions
and topological similarity of genes in the interaction network. PANDA trains a graph
deep learning classier using the input of the human molecular interaction network
(HMIN) and predicts and ranks the probability of autism association of every node
(gene) in the network. PANDA was able to achieve a high classication accuracy of
89%, outperforming three other commonly used machine learning algorithms. More-
over, the gene prioritization ranking list produced by PANDA was evaluated and
validated using a large-scale independent exome-sequencing study. The top decile
(top 10%) of PANDA ranked genes were found signicantly enriched for autism as-
sociation.
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Chapter 1
Introduction
Biomedicine studies acknowledge that susceptibility to common diseases is multifacto-
rial, and both genetic and environmental factors play a crucial role [1]. Abnormalities
in certain genes can either predispose individuals to a disease or directly account for
the manifestation of a disease phenotype [2]. Thereby, deciphering the association
of genes with a specic disease helps better understand the etiology of the disease,
leading to better diagnosing the disease, designing therapeutic strategies, and even
preventing the disease [3, 4, 5].
Understanding the genetic etiology of complex diseases is one of the greatest chal-
lenges in modern biomedicine research [6, 7, 8]. Many common diseases are specu-
lated to have complex genetic architecture, and a substantial number of genes may
contribute collectively to the manifestation of a disease [9, 10]. However, the identi-
cation of genes associated with a disease, such as linkage studies [11], genome-wide
association studies [12] and RNA interference screens [13], requires time-consuming
and expensive biological experiments to evaluate a considerable number of possible
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candidates [14, 15, 16, 17].
Computational methods in silico can successfully facilitate more targeted down-
stream biological evaluation experiments [18]. Cooperative endeavours are requested
from various research elds, ranging from computer science and statistics to bio-
chemistry. Due to the interdependencies of molecular components, identifying genetic
variants contributory to a disease needs not only to systematically study molecular
functionality independently but also to look into the interconnectivity of molecular
components [19]. In order to identify disease-associated genes, systems biology has
seen increasing applications of computational approaches that model the interactions
among multiple constitutes in human cellular systems [6, 20, 21, 22, 23].
The inheritable disease we are particularly interested in is autism spectrum disor-
der. Autism is a neuropsychiatric disorder characterized by impaired social interaction
and communication, repetitive behaviour, and restricted interests [24]. Sequencing-
based studies suggest that complex neurodevelopmental phenotypes of autism are
driven by a multitude of genomic variants across the genome [25, 26, 27]. Large-scale
family-based exome sequencing studies have unraveled autism-associated genetic vari-
ants [28, 29, 30, 31]. Although over 1,000 genes have been identied to inuence
autism susceptibility, only about 7% of them have shown signicant associations with
the disease [32, 33, 34].
Technological advances in genomics have led to an explosion of molecular and
cellular data from large number of samples. The rapid increase in biological data
dimension and acquisition rate is challenging conventional analysis of disease-gene
associations. With impressive recent advances made in applications ranging from
computer vision to natural-language processing, deep learning methods, a class of
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machine learning techniques, have demonstrated the promising capability of identi-
fying highly complex patterns in large datasets. The crux of deep learning problems
is searching for appropriate representations for input data, which makes the learned
representations amenable to the task at hand.
The combination of genetics and molecular biology has greatly facilitated the
identication of candidate genes for human diseases. Genes associated with similar
disorders show a higher likelihood of physical interactions between their products.
The molecular interconnectivity in human suggests the complex genetic architecture
of autism, meaning that the genetic abnormality of autism is not restricted to the
activity of single gene aberration, but can involve multiple genes from dierent molec-
ular pathways [35]. Although the data are complex, the network information is very
important for bioinformatics analysis of autism-associated genes, since the topological
and interaction information often have a clear biological meaning.
To address these challenges, network science [36] recently has seen ever increasing
applications to disease-gene association studies. Network science studies entities (as
nodes) and their pairwise relationships (as edges), and can be a powerful tool to dis-
cover interaction patterns among biological components. To unravel the links between
genes and diseases, network algorithms rely on the premise that phenotypically simi-
lar diseases are caused by genes that are functionally related. Previous network-based
studies have demonstrated that cellular interaction networks, i.e., protein-protein in-
teraction networks, gene co-expression networks, and metabolic networks, can be used
to understand the molecular basis of gene-disease associations [37, 38, 39, 40, 41, 42].
On the other hand, machine learning techniques have been extensively explored
in disease genomics research [43]. Particularly, with the impressive recent advances
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in computer vision and natural-language processing, deep learning has been rapidly
gaining popularity in bioinformatics as well [44]. The exibility of multi-layered
neural networks extends their usage of diverse datasets, ranging from DNA and RNA
microarrays to gene expression proles [45, 46, 47, 48, 49]. However, standard deep
learning approaches intuitively take data in Euclidean domain as input, such as images
(2-dimensional space), text(1-dimensional space), and gene expression proles (n-
dimensional space) [50], and do not explicitly process data from the non-Euclidean
domain, such as graphs [51]. This limitation holds back its utilities for data naturally
represented as graphs, such as biological networks, social and knowledge networks,
and physical systems.
Graph neural network (GNN) has recently become a promising technique of learn-
ing with graph-structured data [52]. GNN is a family of deep learning methods that
directly analyze data structured as graphs [53]. GNN can extract local spatial fea-
tures on both node- and graph- levels directly from a graph and compose them to
build highly expressive representations, not only capturing the high nonlinearity of
the graph but also preserving the spatial patterns of the nodes [51]. Due to its out-
standing performance on various applications, such as social networks [54], protein
interface inference [55], physical systems [56], and knowledge graphs [57], GNN has
been receiving a surge of attention on dierent graph inference tasks, such as node
classication, link prediction, and graph classication. Although many machine learn-
ing approaches have been proposed in order to predict disease-associated genes, to
the best of our knowledge, few have explored the idea of designing GNN approaches
for the task.
In this thesis, we proposed a bioinformatic framework, Prioritization of Autism-
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genes using Network-based Deep-learning Approach (PANDA), and aimed to identify
potential genes associated with autism across the human genome by designing a
GNN classier that used the human molecular interaction network (HMIN) as input
for training. Our research starts by constructing the HMIN, which provides a scaold
of the connectivity patterns and structural properties of autism-associated genes. We
then compile the set of autism-associated genes, which was used to train the GNN
and to discover novel genes that may associate with autism.
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Chapter 2
Related Work
2.1 Disease-gene association studies
Many common human diseases can be observed passing from one generation to the
next. The information about the genetic basis of human diseases lies at the heart
of precision medicine and drug discovery [58]. Understanding what genes cause a
specic disease helps better diagnose and treat the disease, and may even prevent
the disease if predicted accurately at early stages and eective preventive actions are
taken. However, the associations of genes and diseases are still largely unknown, and
research is required to study and predict such relationships.
In recent years, with the completion of the Human Genome Project [59], genetic
markers spanning the entire human genome have empowered widespread mapping
eorts based on linkage analysis using families with a number of aected individuals,
leading to the discovery of multiple genes for Mendelian diseases. Yet, linkage stud-
ies have had only limited success in identifying genes for complex diseases, such as
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autism, heart disease, cancer, and psychiatric disorders. With the improvement in
genotyping technology, focuses have been shifted from gene mapping in humans to ge-
netic association studies [60]. With greater power and resolution of disease-associated
gene locations than linkage analysis, genetic association studies provide renewed hope
for mapping genes to complex diseases.
Disease-gene association studies are a group of approaches to associate candidate
genes with common diseases [61]. Research on the relationships between genes and
diseases has accelerated as a result of both the completion of the human genome [59]
and the advance of the Next Generation Sequencing technologies [62]. In contrast to
genome-wide association studies (GWAS), which scan the entire human genome for
common genetic variations, disease-gene association studies often focus on exploiting
genetic alterations with pre-specied genes of interest with a priori knowledge about
their functional impact on the disease in question.
A disease-gene association study is considered as a useful initial step in exploring
potential causal pathways between genetic markers and complex diseases. Once a
statistically signicant association of a gene is ascertained, the same gene and its
variants can be further examined in independent populations [63]. In addition, the
identied genes and variants allow molecular biologists designing experiments to nd
their functional roles in biological processes and disease pathology, providing strong
support for causality.
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2.2 Network science-based disease-gene association
studies
Networks are ubiquitous [36]. A network is a collection of nodes joined together in
pairs by edges. They are natural representations for encoding relational structures
encountered in many complex systems, such as biological systems, social networks,
and physical systems [36]. Networks capture the patterns of interactions between the
components of a complex system. For instance, connections in a social network af-
fect how people learn, shape opinions, and diuse ideas, as well as other less obvious
phenomena, such as the spread of disease. In biology elds, biological networks ag-
glomerate the interactions of molecules in living cells, which provide the perspectives
in understanding the dynamics and mechanisms of complex biological systems.
A major challenge in systems biology and medical genetics is to understand how
interactions among genetic variants contribute to complex diseases. Networks have
become an emerging trend for representing the structure of a cellular system that
creates a bridge between biological data and a large toolkit of powerful analysis tech-
niques. Indeed, the enormously complex interactions among molecules within a cell
and even among cells present researchers diculties to acquire knowledge from them.
Over the past decades, systems biology and medical genetics have seen rapid advances
in network biology [64]. Increasing number of studies have utilized network-based
analysis to unravel the relationships between a group of genes and a disease of inter-
est [23, 65, 66].
Yonan et al. [67] constructed gene pathway networks based on prior genetic evi-
dence from the allelic association literature to query the known transcripts within the
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1-LOD (logarithm of the odds) support interval for each region. They used biological
databases and the pathway networks to identify a subset of biologically meaning-
ful, high priority candidates, which contained 383 positional autism candidate genes.
Corominas et al. [68] introduced an interactome mapping approach by experimen-
tally identifying interactions between brain-expressed alternatively spliced variants
of autism risk factors. Suthram et al. [69] presented the rst approach integrating
high-throughput datasets such as mRNA expression and large-scale protein-protein
interaction networks to discover human disease relationships in a systematic and
quantitative way.
Other network-based studies on disease-gene association have also focused on the
protein-protein interaction (PPI) network. Sun et al. [6] analyzed and compared
four publicly available disease-gene association datasets and applied three disease
similarity measures, namely annotation-based measure, function-based measure, and
topology-based measure, to estimate the similarity scores between diseases. The
result demonstrated that the predicted disease associations correlated with disease
associations generated from genome-wide association studies signicantly higher than
expected at random. A recent study [41] focused on studying the protein-protein
interaction network structure of disease pathways. They dened dierent sets of
proteins associated with diseases and found that disease pathways are fragmented
and sparsely represented in the PPI network, and that spatial clustering of disease
pathways within the PPI network is statistically insignicant.
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2.3 Machine learning-based disease-gene associa-
tion studies
Machine learning techniques have been extensively explored in computational biology
under various scenarios, such as classication, regression, clustering, and feature se-
lection [43]. A machine learning approach optimizes a performance criterion by using
example data or past experience. Machine learning-based computational approaches
provide a convenient framework for taking advantages of the exponential growth of
the amount of available biological data [70].
The use of machine learning methods in the context of genome-wide data on ge-
netic variants has yielded an ever-growing number of studies in recent years, compared
to a large number of machine learning studies on other types of genomic datasets,
especially genome-wide gene expression proles [71, 72]. Further, the combination of
predictive modeling and disease-gene association studies have yielded quite positive
results [71]. Indeed, many studies have suggested that the use of machine learning
approaches are capable of identifying genes contributing to certain diseases [72, 73].
In recent years, advanced computational and engineering methodologies have been
employed to meet the needs of cross-disciplinary applications in biomedicine. Brown
et al. [74] introduced a method of functionally classifying genes by using gene expres-
sion data from DNA microarray hybridization experiments. The method was based
on support vector machines (SVMs). The method demonstrated that SVMs could
accurately classify genes into functional categories based on expression data. SVM
as a popular supervised learning algorithm has been used by other studies aiming
to prioritize autism genes. Kou et.al [75] applied several SVM kernels to prioritize
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autism gene candidates based on curated lists of known autism genes. The proposed
approach aimed to learn an SVM classier for prioritizing pluripotency stem cell reg-
ulators from RNAi screens using microarray and ChIP-seq data. Duda et al. [76]
constructed a machine learning model by leveraging a brain-specic functional rela-
tionship network (FRN) of genes to produce a genome-wide ranking of autism risk
genes. Through functional enrichment analysis on their highly prioritized candidate
gene set, they identied a small number of pathways that are key in early neural
development, providing further support for their potential role in autism. Recently,
Krishnan et al. [77] developed a machine-learning approach based on a human brain-
specic gene network to present a genome-wide prediction of autism risk genes. By
using the linkage of nodes, they identied a large set of autism genes converges on a
smaller number of key pathways and developmental stages of the brain.
2.4 Deep learning on biological data
While conventional machine learning approaches have seen great potential for making
use of genetic data, they were limited in their ability to process natural data in their
raw form [78]. Moreover, the rapid increase in biological data dimension and acqui-
sition rate is challenging conventional analysis strategies. Decades-long eorts have
been put to constructing machine-learning systems that required carefully manually-
engineered features. Considerable domain experts need to design an eective feature
extractor that transformed the raw data into a suitable internal representation from
which a model is able to learn.
Impressive advances in computer vision and natural-language processing have been
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revolutionary over the past decade [79]. Deep learning, a family of neural network-
based machine learning methods, has been rapidly gaining in popularity among bioin-
formatic scientists [44]. The exibility of multi-layer neural networks extends their
applications on diverse genetic datasets from DNA and RNA microarrays to gene ex-
pression proles [45, 46, 47, 48, 49]. However, standard deep learning approaches intu-
itively take data in Euclidean domain as input, such as images (2-dimensional space),
text(1-dimensional space), and gene expression proles (n-dimensional space) [50],
and do not explicitly process data from the non-Euclidean domain, such as graphs [51].
This limitation holds back its utilities for data naturally represented as graphs, such
as biological networks, social and knowledge networks, and physical systems.
To better utilize the graph-structured datasets, representation learning on graphs
has shown its eectiveness in many learning tasks, such as prediction or classica-
tion [80]. Deep-learning methods can serve as representation-learning methods with
multi-level representation, allowing a model to deal with raw data and to automat-
ically discover suitable representations for downstream learning tasks. Deep neural
networks (DNNs) are ecient algorithms based on the use of compositional layers
of neurons. Figure 2.1 displays the general workow of a deep neural network. In
computational biology, their appeal is the ability to derive predictive models without
a need for strong assumptions about underlying mechanisms, which are frequently
unknown or insuciently dened.
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Figure 2.1: Schematic ow of deep learning approaches. A deep neural network is
parameterized by its weights on each layer. A loss function measures the quality of
the network output. The loss score is used as a feedback signal to adjust the weights.
2.5 Graph neural network
As stated in the previous section, data in many scientic elds can be represented as
graphs, including biological, nancial, social, and knowledge networks [36]. Graphs
can not only serve as useful structured knowledge repositories but also play a vital
role in modern machine learning [81]. Thus researches of learning on graphs have
been receiving ever-growing attention due to the great expressive power of graphs.
For example, modeling physics systems, learning molecular ngerprints, predicting
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protein interfaces and classifying diseases require that a computational model learns
from graph inputs.
Graph-structured data contains rich geometric relational information among ele-
ments of a complex system. As a unique non-Euclidean data structure for machine
learning, statistical analysis of graphs focuses on node classication, link prediction
and clustering [82]. Traditionally, machine learning algorithms rely on domain expert-
dened heuristics to extract features in order to encoding structural information about
a graph [83]. In recent years, exploiting graph-structured data eectively inspired the
advances of graph neural networks [84].
Graph neural network (GNN) is a family of deep learning algorithms that operate
on a graph and organize their computation over the graph structure [53]. GNNs
are connectionist models that capture the dependence of graphs via message passing
between nodes of graphs. The primary goal of GNNs is nding an eective way to
encode graph structure, so that the downstream learning tasks can exploit the graph.
For various graph learnings tasks, e.g., node classication, clustering, and edge
prediction, GNNs often require dierent designs. GNNs broadly follow a recursive
neighborhood aggregation scheme [53]. Similar to message passing, each node ag-
gregates feature vectors of its neighbors to compute its new feature vector. After
k iterations of aggregation, a node is represented by its transformed feature vector,
which captures the structural information within the node's k-hop neighborhood.
In chapter 4, we describe in detail the framework and computation procedures of a
general GNN.
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2.6 Summary
In this section, we introduced the concept of disease-gene association and its position
in exploring potential causal pathways between genetic markers and complex diseases.
We then described two main trends of computational approaches to disease-gene
association studies. The rst trend is to apply the concepts and tools of network
science to model and analyze the underlying interaction relationships among genes
in human cells. The second trend is to design machine learning-based methods to
nd the models aiming at predicting the disease-associated genes and interpreting
their roles in the etiology of the diseases. Finally, we introduced the concepts and
applications of deep learning, especially graph neural network, on the biological data,
which demonstrated their power and exibility to explore the genomic data.
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Chapter 3
Disease-Gene Association Studies
for Autism
3.1 Background
3.1.1 Autism spectrum disorder
Autism spectrum disorder is a neurodevelopmental disorder typied by striking decits
in social communication and genetically by a mixture of de novo and inherited vari-
ation contributing to liability [85]. Numerous epidemiology studies have reported
that 1 in 68 children is diagnosed with autism, with a 3 to 4-fold increased risk for
boys [86]. Family and twin studies have found that autism is highly heritable, most
caused by a combination of genetic and environmental inuencers [87]. The genetic
risk factors behind autism, however, are highly heterogeneous and over a thousand
genes across the genome are estimated to be involved with no single gene accounting
for more than 1-2% of the cases [23, 88]. Almost all genetic risk factors for autism can
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be found in the general population, but the eects of these risk factors are unclear in
people not ascertained for neuropsychiatric symptoms [89].
Sequencing-based discovery eorts have produced valuable catalogs of genetic vari-
ants that point toward potential causal autism genes [90]. Decades-long eorts to
explain the causes of autism have produced an impressive list of disease-gene associ-
ations. Yet only a small fraction of potentially casual genes are known with strong
genetic evidence from sequencing studies [77]. Unraveling the genetic background of
autism serves a number of goals. One aim is to identify genes that modify the suscep-
tibility to autism. When a set of autism risk genes can be identied with signicantly
high frequencies, we have the potential information to learn about the pathogenesis
of the disease, and we can identify possible targets for therapeutic interventions. An-
other goal is to classify autism patients on the spectrum according to their risk for
autism or to make risk predictions on autism.
Recently, copy number variations (CNVs) were strongly associated with autism [91].
Additionally, autism is consistently associated with a number of specic genetic dis-
orders such as Fragile X syndrome amongst others [92]. Single-gene variants are also
linked to rare cases of autism [93]. The high genetic heterogeneity of autism poses an
enormous challenge for understanding disease etiology.
3.1.2 Autism gene databases
To establish our understanding of autism-associated genes, we explored three ma-
jor databases, including SFARI Gene 2.0 [94], AutDB [95] and Online Mendelian
Inheritance in Man (OMIM) [96]. Each resource gathered data from sources with
17
dierent levels of evidence, ranging from recurrent mutations in patients with autism
to nebulous links gleaned from text-mining thousands of PubMed abstracts.
SFARI Gene 2.0 database is a web-platform developed for the ongoing collection,
curation, and visualization of genes linked to autism in order to enable systematic
community driven assessment of genetic evidence for individual genes with regard to
autism. Several types of genetic variations, such as common variants of small eect or
single-gene variants of large eect, can contribute to autism [89]. Structural variations
in the genome, such as microdeletions or duplications, are also associated with the
disorder [97]. Therefore, SFARI database keeps track of numerous susceptibility genes
uncovered by advanced high-throughput approaches.
AutDB is a publicly available web-portal repository for on-going assembling, man-
ual annotation, and visualization of genes associated with autism [95]. The content
of AutDB is gleaned entirely from published scientic literature and is manually an-
notated by expert biologists. Online Mendelian Inheritance in Man (OMIM) is a
comprehensive, authoritative compendium of human genes and genetic phenotypes
that is freely available [96].
3.1.3 Network biology for molecular interaction network
A key aim of research on postgenomic biomedicine is to systematically study all
molecules and their interactions within a living cell. Network biology [39] has brought
about a shift in the paradigm of elucidating disease pathologies from analyzing the
impacts of single genes to understanding the structures and dynamics of molecular
interaction networks [98]. Indeed, most phenotypes reect the interplay of multiple
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molecular components that interact with each other. Network-based analysis strate-
gies oer a quantiable description of various biological systems [69].
Molecular interaction networks have been exploited to nominate novel candidate
disease-associated genes, based on the assumption that the neighbors of disease-
related genes in a network are more likely to be involved in similar disease traits.
Such interconnectivity implies that the abnormal function of a molecule is not only
conned to that molecule but can spread along the links in the network, which re-
sults in a dense cluster or community, called disease module. Yet, due to the limited
knowledge of disease-associated genes, only a fraction of the known disease-associated
genes are known to physically interact with each other. This suggests that analyzing
dense communities of known disease-associated genes restricts the discovery of all
disease-associated genes.
The elements of molecular interaction networks range from metabolites to pro-
teins. Understanding the function and dysfunction of over 20,000 protein-coding
genes reveals how proteins assemble into functional modules and networks engaged
in specic biological activities. In this thesis, we construct the human molecular in-
teraction network (HMIN) in order to provide a scaold of gene-gene relationships
that helps identify candidate genes according to their structural similarities to known
autism genes. In the following section, we describe in detail our HMIN.
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3.2 Method
3.2.1 Training set of genes compilation
To collect prior known autism-associated genes as training samples, we compiled the
supervised training set of genes using SFARI Gene 2.0 [94] and Online Mendelian
Inheritance in Man (OMIM) [96]. The SFARI Gene 2.0 database is exclusively for
the autism research community and has a collection of manually annotated autism-
associated genes. It assigned each gene a score ranging from 1 (highest association
condence) to 6 (no role in autism) to quantify its association with autism, see Fig-
ure 3.1. Score 1 and 2 represent the strongest evidence of autism association, score 3
and 4 show relaxed criteria of autism association, score 5 marks genes hypothesized
but without tested associations, and score 6 genes have no supporting evidence to be
related to autism. In addition, the OMIM database is a comprehensive, authorita-
tive and updated knowledge base of human genes and genetic disorders compiled to
support human genetics research and education and the practice of clinical genetics.
As described above, score 5 includes genes for which the only evidence comes
from studies of model organisms, without statistical or genetic support in human
studies and score 6 marks genes whose evidence argues against a role in autism.
Therefore, we retrieved 732 genes of categories 1 to 4 from the SFARI database. In
OMIM, we extracted 28 genes from OMIM using the terms of \autism", \autism
spectrum disorder", \ASD". All data were retrieved in November 2018. Overall, a
total number of 760 autism-associated genes were used as positive instances for the
supervised training in the proposed method (a.k.a. PANDA).
On the other hand, we retrieved 1,146 genes that have shown no association as
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Figure 3.1: Score categories of SFARI genes. Score 1 and 2 represent the strongest
evidence of autism association, score 3 and 4 show relaxed criteria of autism associ-
ation, score 5 marks genes hypothesized but without tested associations, and score 6
genes have no supporting evidence to be related to autism. In the gure, each point
represents the mapping of a score category and its associated number of reports, and
the size of a point denotes the number of genes that have the given score and the
corresponding number of reports.
the negative instances curated by brain-disease experts [76]. Our integrated HMIN
covered 1,102 out of the 1,146 genes. Given the fact that genes in the positive set have
dierent strengths of association with autism, we placed them into three condence
levels, where each level was assigned with a condence value from f0.5, 0.75, 1.0g (see
Table 3.1). For the set of negative genes, their condence values were set to  1:0.
The association with autism of the positive and negative genes served as the labels
of our training set genes for the subsequent supervised training of the classier in
PANDA.
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Table 3.1: Gene labels based on their condence levels of autism association
Condence Data Source
1.0 Genes in SFARI category 1
0.75 Genes in SFARI category 2 and OMIM autism entry
0.5 Genes in SFARI category 3 and 4
-1.0 Genes without autism association
3.2.2 Human molecular interaction network
We integrated the HMIN based on two sources. The rst data source was a previ-
ously well-established human protein-protein interaction network [99]. This network
included data curated up to 2015. We updated this network by integrating newly
discovered protein-protein interactions using BioGRID version 3.5.167, released on
November 25th, 2018 [100]. BioGRID is a public repository with data of genetic and
protein interactions.
Our HMIN has 23,472 nodes (genes) and 405,618 edges (interactions), representing
their pairwise relationships. The HMIN covers 732 positive autism-associated genes
and 1,102 negative genes in our training set (Section 3.2.1). It included physical
interactions experimentally annotated in human cells, such as transcription factor
regulatory interactions, metabolic enzyme-coupled interactions, and protein-protein
interactions. Note that we treat the HMIN as an unweighted and undirected network.
The hypothesis is that the manifestation of autism is unlikely a consequence of the
dysfunction of a single gene product, but implies various pathological processes that
interact as captured in the HMIN [19]. The interaction patterns of known autism-
associated genes may imply these pathological processes, and can be utilized to predict
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novel autism genes. Therefore, we use such an interaction network and aim to discover
candidate genes that are structurally similar to known autism-genes.
In the rst-stage experiments, we investigated both global and local network prop-
erties of the HMIN and autism-associated genes in the HMIN. Here, we briey describe
the denitions of the global network properties.
 Giant connected component: A component is subgraph G0 of network G
that the sets of its nodes and edges are subsets of those of G. A graph is
connected if there is a path, which is a sequence of edges, between any pair of
its nodes. A giant connected component refers to a connected subgraph of the
network larger than any other connected components that includes the majority
of nodes.
 Average shortest path length: A path is a sequence of nodes P = (v1; v2; :::; vm)
where vi and vi+1 are connected by an edge for i 2 [1;m). In an unweighted
network, the path length equals the number of edges traveled in the path. Due
to the possible existence of multiple paths between any pair of nodes, the short-
est path between a pair of nodes is dened as the one with the shortest length.
Thus the average path length in the network is the average length of the shortest
paths between every pair of nodes.
 Network diameter: The diameter of a network refers to the longest shortest
path in the network. The denition is as D = max(di;j); 8vi; vj 2 V(G), where
di;j is path length for nodes within the same connected component.
 Network density: The density of a network refers to the ratio of the number of
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edges and the number of possible edges. Network density measures the sparsity
of the network.
 Clustering coecient: It is dened as the fraction of length-two paths in the
network that are closed. The path P = (v1; v2; v3) is closed if there exists a third
edge from v3 to v1. Clustering coecient quanties the degree of transitivity in
the network, indicating the likelihood of an interaction (i.e. connected by an
edge) between gene products A and C given that there are edges between gene
products A and B as well as B and C.
As local network properties, centrality quanties how important nodes are in a
network. We used four network centrality metrics, whose denitions are as follows:
 Degree centrality is the number of edges connected to a node.
 Betweenness centrality measures the extent to which a node lies on paths
between other nodes.
 Closeness centrality is a centrality score that measures the mean distance
from a node to other nodes.
 Eigenvector centrality is an extension of degree centrality. Eigenvector cen-
trality awards a number of points proportional to the centrality scores of the
neighbors.
Apart from the network properties stated above, we also utilized three other net-
work metrics, including k-coreness, personalized PageRank and graphlets. Their def-
initions are as follows:
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Figure 3.2: The orbits of 4- and 5-node graphlets. Each isomorphic orbit is rendered
using four dierent colors { white, blue, green and red. The colors do not distinguish
the importance of each orbit.
 k-coreness The k-core of graph is a maximal subgraph in which each node has
at least degree k. The coreness of a node is k if it belongs to the k-core but not
to the (k + 1)-core.
 Personalized PageRank is a weighted version of conventional PageRank [101].
The weights in personalized PageRank are dened by users.
 Graphlets A graphlet is a small connected non-isomorphic induced subgraph of
a large network [102]. Orbits refer to distinct positions of vertices in a graphlet.
There are 69 dierent orbits in 4- and 5-node graphlets, see Figure 3.2.
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Table 3.2: Network properties of the HMIN
Property Value
Number of nodes 23,472
Number of edges 405,618
Number of connected component 4
Network Diameter 8
Network Density 0.001473
Clustering coecient 0.107435
Average node degree 34.561861
Average shortest path length 3.203211
3.3 Results
3.3.1 Investigation of the HMIN
First, we investigated the global network properties of HMIN. Table 3.2 shows some
fundamental network properties of the HMIN. In the HMIN, each node has a degree
ranging from 1 to 2,393 with an average of 34.562. The degree distribution of the
HMIN can be seen in Figure 3.3, which is approximately a power-law distribution,
suggesting a scale-free structure. Most of the genes only interact with a handful of
other genes, while some can interact with one or two thousands of others.
The HMIN is highly connected, with only four components, and the giant con-
nected component (GCC) includes 23,465 nodes. The other seven nodes form islands
of two to three nodes. We used the GCC of the HMIN as the input network to train
the GNN classier in PANDA, described in Chapter 4. Moreover, the average shortest
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Figure 3.3: The node degree distribution of the HMIN. The distribution is approxi-
mately power-law, suggested by the straight line correlation in a log-log scale.
path length is roughly 3, suggesting that the HMIN has a small-world property [103].
The small-world eect of HMIN implies that the neighbors of two given nodes are
likely to be neighbors of each other and most genes can be reached from every other
gene by a small number of steps.
3.3.2 Investigation of the known autism-associated genes
We inspected the degree distribution of autism-genes in the GCC of HMIN. Figure 3.4
shows the distribution of autism-genes. The degrees of autism-associated genes range
from 1 to 665 with the average degrees of 76.32368. Nodes of unusually high degree
are called hubs. The hubs of the GCC are at least 1267 degrees. Compared with the
hubs of the HMIN, autism-genes usually are distributed peripherally in the HMIN.
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Figure 3.4: The degree distribution of autism-associated genes in the GCC. In the
gure, the scales of x-axis and y-axis are natural numbers. The majority of autism-
associated genes are distributed peripherally in the GCC of the HMIN.
To further investigate the distribution structures of autism-associated genes, we
extracted the subgraphs from the HMIN using the autism-associated genes as seeds.
Table 3.3 summarizes the size and number of detected subgraphs. The majority of
known autism-associated genes are connected within a large component with 643
nodes. On the other hand, the rest of the autism nodes are scattered in the HMIN,
suggesting that there may exist other uncovered autism-associated genes that can
joint the large component with the remaining nodes.
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Table 3.3: Measurements of subgraphs extracted using autism-associated genes in
HMIN.
Subgraph sizes Number of occurrence
634 1
2 2
1 121
3.4 Summary
In this section, we rst introduced the denition of autism spectrum disorders and
described the databases of autism genes. Then, we described in detail the human
molecular interaction network and the network properties we used as node properties
in later study. We performed initial network analysis of our HMIN and the known
autism-associated gene in the GCC. The results demonstrated an approximate power-
law distribution of the degrees in the HMIN. Further analysis of the degree distribu-
tion of the autism-associated genes indicated that most of the known autism genes
are peripherally distribution in the GCC of the HMIN. In the coming section, we will
describe in detail our design of PANDA algorithm.
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Chapter 4
Prioritization of Autism-Genes
Using Network-Based
Deep-Learning Approach
4.1 Background
4.1.1 Learning on networks
4.1.1.1 Network embedding
Network embedding is an important approach to learn low-dimensional representa-
tions of nodes in networks, aiming to capture and preserve the network structure [104].
Modeling the interactions between entities as graphs has enabled scientists to under-
stand the various network systems in a systematic manner [36]. Network embedding
is capable of supporting subsequent network analytic tasks, such as node classica-
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Figure 4.1: The illustration of network embedding [84]. In the third panel, the dif-
ferent colors denote that after embedding, dierent nodes are transformed to distinct
representation of the original graph space. Each row of the embedding matrix is the
embedding of the corresponding node.
tion, link prediction, clustering, and network visualization, yielding insight into the
structure of society, communication patterns, and dierent mechanisms of biological
components, see Figure 4.1 [84].
Typically, a model dened to solve graph-based problems either operates on the
original graph adjacency matrix or on a derived vector space. Essentially, network
embedding exploits the latter way to represent network structures. Many approaches
have been proposed to represent network structure [84, 83]. The traditional techniques
of network representation raise several issues on performing network processing and
analysis. On the one hand, network data represented in the traditional way, e.g.
adjacency matrices, causes severe diculties to design and implementation of parallel
algorithms. On the other hand, traditional network representation is inapplicable for
machine learning methods, especially deep learning.
In the past few decades, neural network-based methods have become widely pop-
ular for the node classication. The primary goal of such methods is that the learned
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embedding space can eectively support the inference of node labels. These methods
can be broadly abstracted into two categories of approaches { methods which use ran-
dom walks to propagate the labels, and methods which extract features from nodes
and apply classiers on them. The embeddings are input as features to a model and
the parameters are learned based on the training data. This obviates the need for
complex classication models which are applied directly on the graph.
In summary, the structure and property preserving network embedding plays a
vital role in subsequent learning tasks. If one cannot preserve well the network struc-
ture and retain the important network properties in the embedding space, serious
information is loss, which consequently hurts the downstream analytic tasks [84].
4.1.1.2 Challenges of network embedding
Obtaining a vector representation of each node in a network is inherently dicult and
presents several challenges which have been motivating research in this eld. The rst
challenge is choosing the property of the graph which the embedding should preserve.
A \good" vector representation of nodes should preserve the structure of the graph
and capture the connection patterns of individual nodes. Due to the plethora of
distance metrics and properties dened for graphs, this choice can be dicult and
the performance may depend on the applications.
Second, most real-world networks are large and contain millions of nodes and
edges. Embedding methods should be scalable and able to process large-scale graphs.
Dening a scalable model can be challenging especially when the model is aimed to
preserve global properties of the network.
Last but not least, nd the optimal dimensions of the representation can be hard.
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The choice can rely on application-specic demands on the approach. For example,
lower number of dimensions may result in better link prediction accuracy if the chosen
model only captures local connections between nodes.
4.1.2 Graph neural network
Graph neural network (GNN) is a family of deep learning algorithms [53]. The concept
of GNNs extends existing neural networks for processing the data represented in graph
domains. GNNs operate on a graph and organize their computation over the graph
structure. In many research problems, data can be represented as graphs, including
biological, nancial, social, and knowledge networks [36]. Exploiting graph structured
data eectively inspired the advances of GNN [84].
For various graph learnings tasks, e.g., node classication, clustering, and edge
prediction, GNNs often require dierent designs. In particular, node classication
aims at determining the labels of nodes based on other labeled nodes and the topology
of the network. In this thesis, we focused on predicting the gene association with
autism, i.e., node classication.
Based on convolutional neural network [105] and graph embedding, GNNs are
proposed to collectively aggregate information from graph structure. Thus they can
model input and output consisting of elements and their dependency. Further, graph
neural network can simultaneously model the diusion process on the graph with
recurrent neural network kernel [106].
Though experimental results showed that GNN is a powerful architecture for mod-
eling structural data, the original GNN is inecient to update the hidden states of
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nodes iteratively for the xed points [51]. In contrast, a multi-layer version of GNN
relaxes the assumption of the xed point, resulting in the capability to obtain a stable
representation of node and its neighborhood.
A network can be mathematically represented as a graph G = (V ; E), where V is
the set of nodes and E is the set of edges. In the context of classication, each node
has a class label. A GNN is able to learn a d-dimensional real-valued representation
hv 2 Rd for every node v in V , which is called its node embedding. A GNN constructs
the node embedding h by aggregating the neighborhood information of a node. The
node embedding can be seen as predictors, which will be used in turn for the prediction
of the class label of a node. Figure 4.2 shows the general framework of GNNs in the
proposed research [53].
The embedding of node v captures its spatial structure in its neighborhood and in
the graph, and can be used to produce an output ov such as the class label. A GNN has
two computation modules, i.e., embedding generation and output generation. First, a
local transition function f , shared among all nodes, aggregates the information from
the neighborhood of each node to update the node embedding. Then, a global output
function g takes a node's embedding as input and returns the prediction of its label
as output. The node embedding hv and the output ov are dened as
hv = f(xv;xnb[v];xco[v];hnb[v]);
ov = g(hv;xv);
(4.1)
where xv;xnb[v];xco[v];hnb[v];hv denote the network properties of v, those of v's neigh-
borhood nodes, the properties of v's edges, the embeddings of v's neighborhood nodes,
and the embedding of v, respectively. The learning of functions f and g can be im-
plemented using feed-forward neural networks [53].
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Figure 4.2: Overview of a general graph neural network (GNN). (a) This example
graph has six nodes fv, A, B, C, D, Eg, where the class label of v needs to be assessed.
A GNN has two essential functions, the local transition function f(), which learns
the embedding representation of a node, and the global output function g(). The
vector xv includes m network properties of node v, such as node degree, centralities,
etc. First, f generates an embedding hi of each node i by iteratively aggregating
its xi and its neighboring nodes' network properties (xnb[i]) and embeddings (hnb[i]).
Then, g uses the embeddings to predict the class label for node v. (b) Both f and g
can be learned using feed-forward neural networks.
4.2 Method
4.2.1 PANDA overview
Our proposed framework, Prioritization of Autism-genes using Network-based Deep-
learning Approach (PANDA), include the following steps. We started by integrating
the human molecular interaction network (HMIN) using the literature of physical
protein interactions experimentally documented, where nodes are proteins mapped to
their corresponding genes, and an edge indicates the existence of interactions between
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Figure 4.3: PANDA overview. Using the graph input of (a) the human molecu-
lar interaction network (HMIN), PANDA employs (b) a ground truth set of known
autism-associated genes as positive instances and a set of genes that have been shown
without autism association as negative instances. The classier learns the structural
patterns of autism-associated genes through (c) a multi-layer graph neural network
(GNN) and (d) predicts and ranks autism associations for all genes in the HMIN.
two genes (Figure 4.3a). We then compiled a set of known autism-associated genes
and a set of conrmed genes without autism association from databases including
SFARI [94] and Online Mendelian Inheritance in Man (OMIM) [96] (Figure 4.3b).
These two sets of genes were used as positive and negative instances for training the
classier. Next, we designed a multi-layer graph neural network (GNN) that used the
HMIN as input (Figure 4.3c). In the nal step, we used the trained GNN classier
to predict and rank the probabilities of all genes in the HMIN that inuence autism
(Figure 4.3d).
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4.2.2 Our GNN in PANDA
In PANDA, we utilized the gene-gene interaction patterns captured by the HMIN,
and designed a deep graph neural network (GNN) that directly takes the graph of
the HMIN as input and outputs a predicted ranking of genes in the HMIN based on
their autism associations.
Following the ideas of the general GNN outlined in the previous section, we pro-
posed a GNN tailored for our PANDA framework. Figure 4.4 presents the node
classication procedure of PANDA. Specically, here we discuss the design of the
node embedding h, the local transition function f , and the global output function g
and its loss function.
We used six network metrics and graphlet orbit frequencies to describe the local
structural properties xv of node v. These six network metrics include betweenness,
closeness, eigenvector centrality, personalized PageRank centrality [107], degree, and
coreness [108]. A graphlet is a small connected non-isomorphic induced subgraph of a
large network [102]. Orbits refer to distinct positions of vertices in a graphlet. There
are 69 dierent orbits in 4- and 5-node graphlets we extracted from the HMIN.
The local transition function f aggregates the network properties of node v and
its direct neighbors (Figure 4.5). Recall that only the training set of genes in the
HMIN have labels, so v's neighbors can contain both labeled and unlabeled nodes.
For the unlabeled nodes u0, we performed the conventional element-wise averaging
over them. For the labeled neighbors u, we computed a weighted average using their
labels (condence values, see Table 3.1). The aggregation was computed as follows
hk 1nb[v] =
1P
u u
X
u
uh
k 1
u +
1
B
X
u0
hk 1u0 ; (4.2)
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Figure 4.4: Schematic demonstration of PANDA for node classication. Here, the
graph with ve nodes and ve edges is a miniature of HMIN. PANDA learns the
node embeddings over the structure of HMIN via a multi-layer graph neural network,
aiming to classify the set of nodes into autism-associated gene (y = 1) and no-autism-
association gene (y =  1). Start from the input layer, each node has a m-dimensional
network property vector xi=f1;2;3;4;5g 2 Rm. Transformed through multiple hidden
layers, every node obtains an d-dimensional real-valued embedding hi=f1;2;3;4;5g 2 Rd.
The output of PANDA is the predicted probabilities of all nodes. In our study, only
a subset of nodes have labels. As shown in the gure, only node x1 and x4 have
labels y1 and y4, respectively. By aggregating information from neighbors, the ve
nodes embeddings transform the representations of the nodes from the original m-
dimensional space to the 2-dimensional space.
where hk 1nb[v] is the (k   1)th-layer aggregated embedding of node v's neighborhood,
hk 1u and u are the (k   1)th-layer embedding and the label of the neighbor node u
of v, respectively, and hk 1u0 is the (k   1)th-layer embedding of the total number of
B unlabeled nodes u0.
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Figure 4.5: Learning the node embeddings. (a) Node i has three neighbors v1; v2; v3,
each assigned with a condence value 1; 2; 3. To update the embedding of i at
layer k, the local transition function f rst aggregates the (k-1)th-layer's embeddings
of i's neighbors, i.e., hk 1nb[i] = (1=
P3
j=1 j)
P3
j=1 jh
k 1
vj
. Next, it concatenates the
embedding of i at layer k   1 with hk 1nb[i], i.e., hk 1i  hk 1nb[i]. Finally, we used a ReLU
function as the activation function that takes as input the concatenated vector and
generates the kth-layer's embedding of i, i.e., hki = ReLU(W
k  (hk 1i  hk 1nb[i]) + bk).
(b) For a K-layer GNN, the embedding generation process is repeated K   1 times.
Then, we combined the embedding hk 1v of v and the aggregated embedding h
k 1
nb[v],
using the concatenation operation  proposed in GraphSAGE [109], which is to
combine two embedding vectors side by side,
CONCATE(hk 1v ;h
k 1
nb[v]) = h
k 1
v  hk 1nb[v]: (4.3)
After the training of the local transition function f and receiving the embeddings
of all nodes in the HMIN, the global output function g was used to predict the
39
Table 4.1: Terms and notations used in PANDA algorithm
Notation Denition
G = (V ; E) Human Molecular Interaction Network
jVj Number of nodes
jEj Number of edges
nb[v] The set of v's neighbors
xv 2 Rm Properties of v in m-dimensional space
yv 2 f1; 1g Desired label for v
y^v 2 f1; 1g Predicted label for v
p^v 2 [0; 1] Predicted autism association probability for v
K Number of layers in PANDA algorithm
 = (W;b) Hyperparameters
class of each node, i.e., the association with autism. We used the sigmoid function
that transformed the prediction result to a probability. We let the nominal variable
yv 2 f1; 1g be the desired label for the node v, where yv = 1 indicates that the
node v is associated with autism, otherwise it is not related to autism (i.e. yv =  1),
and let p^v be the predicted probability of v being associated with autism. We then
projected these probabilities to one of the two labels.
4.2.3 Loss function and optimization
Before we introduce the loss function, Table 4.1 gives the notation used in the PANDA
algorithm.
Since only a subset of genes have labels while the others do not, we designed a
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two-term loss function in PANDA. The rst term of the loss function is a binary
classication cross-entropy loss function for the supervised learning using labeled
nodes [50]. Cross-entropy loss increases as the predicted probability diverges from
the actual label, dened as
Lsu =
nsuX
i=1
 yi log p^i   (1  yi) log(1  p^i); (4.4)
where nsu is the number of labeled nodes, yi is the desired label, and p^i is the predicted
probability.
For the second term of unsupervised learning using unlabeled nodes, a similarity
measurement was employed. Recall that the node embeddings were generated under
the principle that neighboring nodes should have similar embedding vectors. The
similarity between two embedding vectors can be naturally quantied using Euclidean
distance. The second term of the loss function is to penalize the embeddings that
encode neighboring nodes very dierently, dened as
Lun =
nunX
j=1
X
i2nb[j]
jjhj   hijj22; (4.5)
where nun is the number of the unlabeled nodes, hj and hi are the embeddings of
node j and its direct neighbors.
The nal loss function is thus computed as
L = Lsu + Lun + Lreg; (4.6)
where  balances the inuence of unlabeled nodes in the learning,  is the regulariza-
tion weight, and Lreg is an L2-norm regularization term to prevent overtting, dened
as
Lreg = 1
2
KX
k=1
jjWkjj22; (4.7)
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where K is the number of layers of the GNN.
4.2.4 Training and cross-validation
We adopted a ve-fold cross-validation scheme to train the classier in PANDA.
First, we randomly split the labeled genes into ve partitions. In each of the ve
iterations, we trained the classier using four partitions and evaluated the classier
on the remaining testing partition. For an unlabeled node, its nal predicted label
is computed by averaging the predictions of the ve iterations. After obtaining the
predictions for all nodes in the HMIN, we ranked the nodes in the descending order
of their predicted probabilities. This rank list represents PANDA's prioritization of
candidate autism-associated genes. The pseudocode of this learning algorithm in
PANDA is shown in Algorithm 1.
4.3 Results
We implemented the GNN training in PANDA using TensorFlow [110] with Adam
optimizer [111]. We trained the GNN classier using the giant connected component
of the HMIN as the input network. The number of layers of our GNN was set to
4. We set the dimension of the embeddings to 10. The hyperparameters of ; 
were tuned by grid search on the cross-validation partitions. Considering the model
variance, we repeated the ve-fold cross-validation 20 epochs. We reported the accu-
racy from the epoch with the lowest validation error. We evaluated the autism gene
ranks predicted by PANDA by validating using data from an independent sequencing
study and comparing the prediction performance with three other machine learning
42
methods.
Algorithm 1: The learning algorithm in PANDA.
Input: HMIN G = (V ; E); node properties and labels(X;Y); condence
vector ; number of PANDA layers K; model parameters  = (W;b)
Output: Predicted probabilities P^, node label predictions Y^, and trained
parameters updated
1 h0v  xv; 8v 2 V
2 repeat
3 for k = 1; ::; K   1 do
4 for v 2 V do
5 hk 1nb[v]  1Pu u
P
u uh
k 1
u +
1
B
P
u0 h
k 1
u0
6 hkv  ReLU(Wk  (hk 1v  hk 1nb[v]) + bk)
7 end
8 hkv  hkv=jjhkv jj; 8v 2 V
9 end
10 y^v; p^v = (W
K  hK 1v + bK)
11 Lhybrid = Lsu + Lun + Lreg
12 use stochastic gradient descent to update the parameters 
13 until converge;
14 return P^ = fp^v; 8v 2 Vg; Y^ = fy^v; 8v 2 Vg; updated
4.3.1 Classication performance of PANDA
We computed several performance measurements to evaluate the classier in PANDA.
The GNN classier has a sensitivity of 0:95, a specicity of 0:86, and a classication
43
accuracy of 0:89. We further looked at Precision@k, dened as the proportion of
genes in the top-k ranking list by PANDA that are known associated with autism
(positive genes), and computed as
precision@k =
jtop-k \asdj
k
: (4.8)
Here, top-k and asd are the set of top k genes from the predicted ranking list and
the set of known autism-associated genes, respectively. \ is the operation of set inter-
section. Figure 4.6 shows that 24.7% of the top-2000 ranked genes are known autism-
associated genes, i.e., 494 (= 200024:7%) out of a total 760 autism-associated genes
have been successfully identied by PANDA in the rst decile of its ranking list.
4.3.2 Model sensitivity and specicity
Apart from testing the computational results in silico, we used an independent se-
quencing study [29] to validate the autism genes prioritized by our method. This
whole exome-sequencing study examined 2,508 autism probands (autism aected chil-
dren), 1,911 unaected siblings, and their parents in the Simons Simplex Collection
(SSC) [112]. This study focused on identied de novo likely gene-disrupting (DN-
LGD) mutations. It reported 353 target genes identied in autism probands with 27
recurrent genes, and 176 DN-LGD genes in unaected siblings.
We looked at the genes in each decile of the rank list R produced by PANDA and
compared them with the three gene sets, i.e., DN-LGD in probands, recurrent DN-
LGD in probands, and DN-LGD in unaected siblings, reported in the independent
validation study. For each comparison, we applied a one-tail binomial test [113] in
order to assess the signicance of the overlap. Figure 4.7 shows the overlap of these
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Figure 4.6: Precision@k chart. Precision@k is the proportion of genes in the top-k
ranking list that are known associated with autism. We compared our PANDA with
support vector machine (SVM), random forest (RF), and linear genetic programming
(LGP) using the measure of Precision@k.
independently discovered autism-genes in our PANDA rank R. DN-LGD genes were
found enriched in our top 10% of the ranking list (103/353, p = 2:467  10 5).
Moreover, the recurrent DN-LDG genes validated in probands were enriched in the
rst decile (15/27, p = 4:78610 5). No signicant enrichment of the DN-LGD genes
in unaected siblings was found by PANDA (26/176, p = 0:3744).
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Figure 4.7: Distribution of the PANDA ranks for autism genes identied in the in-
dependent exome-sequencing study. (a) Genes with de novo likely gene-disrupting
(DN-LGD) mutations in probands (autism aected children). (b) Genes with recur-
rent DN-LGD in probands. (c) DN-LGD genes identied in unaected siblings. The
rst and second highest deciles are highlighted in blue.
Furthermore, we evaluated the specicity of the gene rankings by PANDA, which is
the ability to downweight non-autism genes or to ensure we were not simply observing
an enrichment for genes involved in brain function. It specically can be used to test
if our enriched genes were associated with general neurological disorders, rather than
specically with autism. Figure 4.8 shows the distributions of the PANDA ranks for
genes associated with Alzheimer's disease, Parkinson's disease, and epilepsy. None
of the three neurological disease genes were signicantly enriched in the top decile
of the PANDA ranking list. The results suggested that our method was able to
identify autism genes rather than genes associated with a broader range of neurological
disorders.
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Figure 4.8: Specicity results of PANDA gene ranking list. (a) The distribution of
PANDA ranks of genes associated with Alzheimer's disease (AD). 1 out of the total
35 AD genes was in the top decile of PANDA ranking and its binomial test p-value
is 0.472. (b)The distribution of PANDA ranks of Parkinson's disease (PD) genes. 3
out of 43 PD genes were ranked in the top decile (p = 0:833). (c) The distribution of
PANDA ranks of epilepsy genes. 11 out of 32 genes were in the top decile (p = 1).
4.3.3 Methods comparison
To evaluate the classication performance of PANDA, we compared the results of
PANDA with using three other machine learning methods, including support vector
machine (SVM) [114], random forest (RF) [115], and linear genetic programming
(LGP) [116]. The parameters of the compared methods are selected by grid search
with cross-validation [117]. We used the Radial Basis Function kernel for SVM. The
number of estimators in RF was set to 100. We set the population size, number of
generations and number of runs in LGP to 1000, 1000 and 100, respectively, and
the crossover and mutation rates to 0.9 and 0.05. To ensure a fair comparison, all
methods used the same ve-fold cross-validation partitions. Figure 4.6 shows the
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comparison result using precision@k. PANDA achieved the best ranking quality of
the top-2000 genes among all four methods. Figure 4.9 shows the comparison result
using the measure of prediction accuracy. PANDA achieved the best classication
accuracy among all four methods.
0.89
0.67
0.63 0.61
0.0
0.2
0.4
0.6
0.8
1.0
PANDA RF LGP SVM
A
c
c
u
ra
c
y
Figure 4.9: Comparison of the classication accuracy using PANDA, support vector
machine (SVM), random forests (RF), and linear genetic programming (LGP).
4.4 Biological interpretation
Prioritizing the candidate autism-associated genes from the HMIN is just one step
toward deciphering the etiology of the disease. As our goal is to facilitate downstream
biological validation tests on potential autism-associated genes, the next step after
ranking the genetic variants via PANDA classier is to explore the top-ranked genes.
To better understand the genetic attributes of the top 10% ranked autism-associated
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candidate genes(~2300 genes), we conducted experiments from two aspects. First, we
extracted the disease module from the HMIN using the top 10% ranked genes. Then,
we utilized DAVID database [118] to analyze the biological characteristics of the top
ranked genes.
4.4.1 Characterization of prioritized autism-associated genes
We took a closer look at the top 10% genes in the PANDA ranking list and investigated
their properties as nodes in the HMIN. Inspired by the proposed concept of disease
module in network biology [19], we dened the autism module as an induced subgraph
of the HMIN that includes the top decile genes predicted by PANDA with regard to
their autism association. The autism module has 2,346 nodes and 11,668 edges.
Following the intuition that functionally related genes tend to share many con-
nections and develop local \neighborhoods" within a larger network, we applied a
fast-greedy community detection algorithm [119] to the autism module in order to
identify the functional neighborhoods. Figure 4.10 shows the communities identied
in the autism module. The modularity rate of the autism module is 0:385, indicating
a signicant occurrence of community structures, i.e., nodes have signicantly more
connections with others within a community than with nodes from dierent commu-
nities. Figure 4.11 shows the pairwise correlations among the six network metrics in
the autism module.
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Figure 4.10: The histogram of the community sizes in the autism module. For the
consideration of clarity, the gure only displays communities with at least 2 nodes.
There are 255 communities that only contain a single node, which is not shown in
the gure.
50
0.00
0.02
0.04
0.06
0.08
0.10
be
tw
ee
nn
es
s
0.00
0.02
0.04
0.06
0.08
0.10
0.12
clo
se
ne
ss
0.0
0.2
0.4
0.6
0.8
1.0
ei
ge
nc
en
trl
−0.0025
0.0000
0.0025
0.0050
0.0075
0.0100
pp
r
0
50
100
150
200
250
de
gr
ee
0.00 0.05 0.10
betweenness
0
5
10
15
20
25
co
re
ne
ss
0.00 0.05 0.10
closeness
0.0 0.5 1.0
eigencentrl
0.000 0.005
ppr
0 100 200
degree
0 10 20 30
coreness
Figure 4.11: The pairwise correlations of six network metrics in the autism
module, including betweenness centrality, closeness centrality, eigenvector central-
ity(eigencontrl), personalized pagerank(ppr), degree centrality, k-coreness.
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4.4.2 Enrichment analysis
The Database for Annotation, Visualization and Integrated Discovery (DAVID) pro-
vides a comprehensive set of functional annotation tools to understand biological
meaning behind a given list of genes [118]. We rst submitted the rst 10% genes
to DAVID database and extracted the results under the categories of Gene Ontology
(GO), Disease, Pathways. Table 4.2 presents the most signicantly enriched func-
tional categories.
We analyzed the functional enrichment tests of the rst 10 communities detected
in the autism module and applied multiple testing correction to adjust the resulting
p-values. For each community, the threshold of gene count is set to 15, indicating that
only functional categories containing more than 15 of the total submitted genes were
included. The signicance cuto as 0.05, i.e. Fisher's exact test p < 0:05. Table 4.3
shows most signicantly annotated diseases enriched for the top 10 communities. We
found that tobacco use disorder had the highest appearance in 8 of the 10 commu-
nities under the GAD DISEASE category, with Schizophrenia for community 4 and
Neuroblastoma for community 7.
We then looked into the enriched KEGG pathways in the 10 communities. For
the pathway enrichment tests, the threshold of gene count is set to 5, indicating that
only functional categories containing more than 5 of the total submitted genes were
included. The signicance cuto as 0.05. Table 4.4 shows the most signicantly
enriched pathways for each community. The results suggest several pathways, which
have been examined in order to determine the involvement in autism.
For example, MAPK signaling pathway is enriched in community 1. The MAPK
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pathway is a prominent intracellular signaling pathway regulating various intracellular
functions [120]. Studies have revealed that components of this pathway are mutated
in a related collection of disorders that are associated with autism [121]. Another
example is cAMP signaling pathway in community 5. cAMP (a.k.a. Cyclic AMP)
is a second messenger involved in many processes including mnemonic processing
and anxiety [122]. It has previously been investigated with regard to its role in
autism [123].
DAVID enrichment tests have yielded insights into the top-ranked genes. First,
the autism module derived using these genes has organized into several functionally
distinct communities. These communities have relevant associations with autism.
Community 1 was enriched for several signaling pathways with previous evidence
of association with autism, such as PI3K signaling pathway, HTLV-1 infection, and
MAPK signaling pathway. Communities 2 and 4 reected multiple biological pro-
cesses, including chromatin remodeling, histone modication, and transcriptional reg-
ulation that have prior implication in autism. Furthermore, the detected communities
captured a number of developmental processes. Community 5 showed embryonic de-
velopment. Neuron fate commitment and nervous system development were enriched
in community 6. Enrichment of axonal and dendritic development and morphogenesis
was contained in community 3.
4.5 Summary
In this section, we rst introduced the concepts and challenges of network embedding,
from which we introduced graph neural network. Section 4.1.2 described in detail the
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fundamental ideas of graph neural network. Based on the original proposal of GNN,
Section 4.2.1 presented the overview of PANDA framework. Section 4.2.2 described
the node classication procedure of PANDA. Finally, we assessed our method from
three aspects, including the model performance, the validation on an independent
study, and biological enrichment test. The results showed that PANDA was able to
achieve high classication accuracy, and that its output gene ranking was successfully
validated using an independent sequencing dataset.
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Table 4.2: Enriched functional annotation terms of the ten communities. The options
of gene count and signicant cuto are set to 15 and 0.05, respectively.
Category Term Count p-value
GOTERM CC DIRECT Nucleus 233 1:6 10 27
GOTERM CC DIRECT Nucleoplasm 155 1:9 10 27
GOTERM BP DIRECT Negative regulation of transcription from
RNA polymerase II promoter
71 7:4 10 24
GOTERM MF DIRECT Zinc ion binding 92 1:2 10 23
GOTERM BP DIRECT Transcription, DNA-templated 123 1:9 10 23
GOTERM BP DIRECT Positive regulation of transcription from
RNA polymerase II promoter
81 3:4 10 22
GOTERM BP DIRECT Negative regulation of transcription,
DNA-templated
52 1:2 10 18
GOTERM MF DIRECT Protein binding 304 1:7 10 17
GOTERM CC DIRECT Cytoplasm 198 3:2 10 15
GOTERM MF DIRECT Sequence-specic DNA binding 65 1:9 10 13
GAD DISEASE CLASS Chemdependency 150 8:1 10 10
GOTERM MF DIRECT DNA binding 82 1:9 10 9
GOTERM BP DIRECT Regulation of DNA-templated transcription 73 2:2 10 8
GOTERM MF DIRECT ATP binding 65 7:7 10 6
GAD DISEASE CLASS Psych 75 8:9 10 4
GAD DISEASE CLASS Developmental 56 6:5 10 3
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Table 4.3: Enriched disease category annotations of the ten communities. The options
of gene count and signicant cuto are set to 15 and 0.05, respectively. The category
is selected as GAD DISEASE.
Community Disease Term Gene Count p-value
Community 1 Tobacco Use Disorder 134 2:0 10 10
Community 2 Tobacco Use Disorder 91 6:5 10 7
Community 3 Tobacco Use Disorder 214 5:4 10 34
Community 4 Schizophrenia 18 1:6 10 4
Community 5 Tobacco Use Disorder 52 8:0 10 6
Community 6 Tobacco Use Disorder 33 5:1 10 4
Community 7 Neuroblastoma 16 6 10 3
Community 8 Tobacco Use Disorder 76 2:1 10 3
Community 9 Tobacco Use Disorder 17 2:2 10 2
Community 10 Tobacco Use Disorder 19 2:5 10 2
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Table 4.4: Enriched pathways category annotations of the ten communities. The
options of gene count and signicant cuto are set to 5 and 0.05, respectively. The
category is selected as KEGG PATHWAYS.
Community Pathway Term Gene Count p-value
Community 1 MAPK signaling pathway 16 1:5 10 4
Community 2 Axon guidance 10 4:5 10 5
Community 3 Glutamatergic synapse 30 4:9 10 18
Community 4 Purine metabolism 15 4:5 10 14
Community 5 cAMP signaling pathway 8 1:7 10 6
Community 6 Serotonergic synapse 6 8:7 10 5
Community 7 Lysine degradation 7 6:7 10 3
Community 8 mRNA surveillance pathway 18 6:5 10 15
Community 9 RNA degradation 14 1:7 10 3
Community 10 N-Glycan biosynthesis 6 5:6 10 3
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Chapter 5
Discussion
5.1 Contribution summary
Elucidating the genetic etiology of complex diseases is one of the greatest challenges
in modern biomedical research. Disease-gene association study is a crucial step in
understanding disease etiology. Deciphering the link between genes and diseases
is an open problem in biomedical sciences, but it presents an opportunity to better
understand disease etiology, thereby allowing for the design and development of better
mitigation strategies. As a result, various in silico methods for predicting associations
from large-volume biological data have been developed using dierent approaches.
Computational methods have seen increasing applications in biomedicine, thanks
to their powerful abilities to analyze large-volume, high-dimensional data. Priori-
tizing disease association genes is a research problem that can benet from using
carefully designed and tailored computational methods. Many common and complex
diseases have observable high inheritance, however, our understanding of their genetic
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architecture is still limited. Complex network analysis and deep learning provide a
powerful toolset that can be used to characterize the inter-connective relationships of
genes in the human genome and to identify potential genes associated with diseases
based on such interaction patterns.
In this thesis, we proposed PANDA, a graph deep learning approach to prioritizing
autism genes across the entire human genome. In PANDA, we rst constructed
the human molecular interaction network (HMIN) to characterize the patterns and
structure of gene-gene interactions in the human genome. We then designed a graph
neural network that was able to input graph structured data, to learn the similarity of
nodes and their interaction patterns, and to predict potential genes that were similar
and related to known autism genes. The results showed that PANDA was able to
achieve high classication accuracy, and that its output gene ranking was successfully
validated using an independent sequencing dataset.
We contribute to the understanding of autism etiology in the following aspects.
Firstly, we developed a deep graph neural network method that can operate directly
on a biological network. PANDA utilized the interaction relationships embedded in
the HMIN to learn hidden features for every node in the network. In line with our
hypothesis that these hidden features encode the connectivity patterns of the autism-
associated genes and distinguish from those of non-disease genes, the PANDA classi-
er achieved high classication performance with 89% accuracy. Secondly, PANDA
not only trained a predictive classier but also generated a prioritization ranking of
genes across the genome. We tested the prioritization quality using an independent
sequencing study, and the results suggest that our top 10% (2346) genes were signif-
icantly enriched for the de novo likely gene-disrupting mutations that are identied
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in autism-aected children, while no signicant enrichment was shown in the autism
unaected siblings. The result elucidates the capability of the PANDA to nomi-
nate candidate autism-associated genes, which can facilitate downstream biological
researches.
In summary, our study showcased the potential of designing advancing network
analysis and machine learning methods for the prioritization of disease-associated
genes. Apart from many existing studies where new genes were often predicted with
disease association based on their direct relationship with known disease genes, we
hypothesized that genes involved in the development of a disease may not directly
interact with each other, but may exhibit similar topological properties in the HMIN.
Using the graph deep learning approach enabled searching for these potential genes
that were multi-hops away from known autism-associated genes. We hope this study
opens future research avenues of employing more advanced modeling and learning
algorithms in order to better characterize the genetic architecture of complex diseases.
5.2 Future work
However, there are limitations in our study. First, we consider that the HMIN are
invariant for autism, meaning that the mutations on certain genes associated with
autism do not introduce a new topology in the HMIN. Second, although Alzheimer
and Parkinson diseases often occur late than autism, we ignored the onset and devel-
opment timepoints of autism and the three neurological disorders.
In future studies, we expect to explore more generic models on prioritizing genes
associated with other diseases or disease subtypes. For the top-ranked candidate
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autism-associated genes, further explorations, such as genome-wide association stud-
ies, can be conducted to gain a deeper understanding of the associations with autism.
In addition, a comparative analysis can be conducted by including more machine
learning methods, particularly other graph learning-targeted algorithms in order to
obtain robust and reasonable conclusions. Moreover, we can develop an application
with a graphical user interface for other biologists to adopt the methods exploited in
this research.
On the other hand, genes carrying mutations associated with genetic diseases are
present in all human cells [124]. Clinical manifestations of complex diseases, how-
ever, are usually highly tissue-specic [125]. Genes with tissue-specic expressions
have shown to be involved in important physiological processes for complex organ-
isms [126]. Although some disease-causing genes are expressed only in selected tissues,
the expression patterns of disease-causing genes alone cannot explain the observed
tissue specicity of human diseases. In the future, we expect to explore the applica-
tion of PANDA over tissue-specic biological networks, which are built using tissue
specicity expression data.
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